ProfileGDS4718 / 1561292_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 23% 13% 24% 21% 14% 14% 29% 27% 28% 22% 36% 23% 30% 23% 21% 23% 20% 26% 21% 30% 31% 18% 13% 18% 23% 24% 27% 24% 26% 17% 17% 21% 24% 24% 22% 22% 22% 17% 20% 18% 21% 18% 22% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2040821
GSM549102patient 115, normal, homogenized [OPG study]4.2754723
GSM549104patient 119, normal, homogenized [OPG study]3.8497513
GSM549108patient 138, normal, homogenized [OPG study]4.343724
GSM549119patient 077, normal, homogenized [OPG study]4.2020321
GSM549133patient 032, cancer, homogenized [OPG study]3.8767814
GSM549139patient 042, cancer, homogenized [OPG study]3.8921114
GSM549099patient 107, normal, homogenized [OPG study]4.5019229
GSM549109patient 139, normal, homogenized [OPG study]4.431527
GSM549110patient 046, normal, homogenized [OPG study]4.4483428
GSM549114patient 063, normal, homogenized [OPG study]4.1912322
GSM549122patient 082, normal, homogenized [OPG study]4.7921136
GSM549134patient 033, cancer, homogenized [OPG study]4.251223
GSM549136patient 036, cancer, homogenized [OPG study]4.4863430
GSM549140patient 044, cancer, homogenized [OPG study]4.213923
GSM549111patient 047, normal, homogenized [OPG study]4.1566121
GSM549113patient 057, normal, homogenized [OPG study]4.2025423
GSM549132patient 031, cancer, homogenized [OPG study]4.1199920
GSM549137patient 038, cancer, homogenized [OPG study]4.3709126
GSM549142patient 047, cancer, homogenized [OPG study]4.2888521
GSM549100patient 110, normal, homogenized [OPG study]4.5714330
GSM549107patient 135, normal, homogenized [OPG study]4.5441331
GSM549115patient 068, normal, homogenized [OPG study]4.0291918
GSM549116patient 072, normal, homogenized [OPG study]3.8891913
GSM549120patient 078, normal, homogenized [OPG study]4.0799618
GSM549131patient 030, cancer, homogenized [OPG study]4.1933123
GSM549118patient 074, normal, homogenized [OPG study]4.3180624
GSM549129patient 027, cancer, homogenized [OPG study]4.438227
GSM549123patient 088, normal, homogenized [OPG study]4.2773224
GSM549124patient 006, cancer, homogenized [OPG study]4.407426
GSM549126patient 015, cancer, homogenized [OPG study]4.022717
GSM549128patient 025, cancer, homogenized [OPG study]3.99917
GSM549103patient 117, normal, homogenized [OPG study]4.2385521
GSM549117patient 073, normal, homogenized [OPG study]4.2617524
GSM549138patient 041, cancer, homogenized [OPG study]4.2889924
GSM549141patient 045, cancer, homogenized [OPG study]4.153822
GSM549130patient 028, cancer, homogenized [OPG study]4.2322322
GSM549101patient 111, normal, homogenized [OPG study]4.2229522
GSM549105patient 128, normal, homogenized [OPG study]4.0333617
GSM549106patient 134, normal, homogenized [OPG study]4.0992120
GSM549112patient 048, normal, homogenized [OPG study]4.0781118
GSM549125patient 011, cancer, homogenized [OPG study]4.1782421
GSM549127patient 024, cancer, homogenized [OPG study]4.032418
GSM549135patient 035, cancer, homogenized [OPG study]4.1661222